Table 4.
Baseline characteristics of HCV mono-infected patients (HCV treated versus untreated)
| Characteristics | Group A: HCV mono-infected patients, treated (n = 52) | Group B: HCV mono-infected patients, untreated (n = 32) | p-values |
|---|---|---|---|
|
Age, mean (min./max.) |
44 (22/65) |
48 (20/72) |
0.112 |
|
Sex, male/female (%) |
34/18 (65/35) |
17/15 (53/47) |
0.264 |
|
Genotype, n (%) |
|
|
|
| 1 |
27 (52) |
22 (69) |
0.129 |
| 2 |
8 (15) |
1 (3) |
0.078 |
| 3 |
12 (23) |
3 (9) |
0.111 |
| 4 |
4 (8) |
1 (3) |
0.390 |
| Unknown |
1 (2) |
5 (16) |
0.018 |
|
Transmission, n (%) |
|
|
|
| IVDU |
28 (54) |
14 (44) |
0.369 |
| Transfusion |
2 (4) |
4 (13) |
0.135 |
| Needlestick injury |
2 (4) |
1 (3) |
0.863 |
| Tatoo |
2 (4) |
0 (0) |
0.262 |
| Unknown |
18 (35) |
13 (41) |
0.579 |
|
HCV RNA in IU/ml, mean (min./max.) |
3 222 000 (3/2 × 107) |
3 810 000 (3/3 × 107) |
0.698 |
| Liver biopsy, n (%) |
27/52 (51) |
9/32 (28) |
0.032 |
| Fibrosis F3 – F4, n (%) | 8/27 (29) | 2/9 (22) | 0.209 |